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Abstract
BACKGROUND: The current coronavirus disease (COVID-19) pandemics induced a modification of daily life and 
clinical practice. Health care workers, particularly dentists and dental hygienists, have been obliged to limit their 
activity and to establish new operative protocols.
AIM: We aimed to discuss an easy protocol for the prevention of cross-infections in dental settings.
METHODS: We revised literature data about COVID-19 and oral health to establish how to work safely with dental 
patients.
RESULTS AND CONCLUSION: A few papers are currently available about the effective prevention of COVID-19 
during dental procedures. Most of the revised articles report a potential strong effectiveness of povidone-iodine and 
its safety for both patients and dental professionals.
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Introduction
The novel coronavirus (CoV), officially named as 
severe acute respiratory syndrome (SARS)-CoV-2, is a 
newly discovered virus, responsible for the so-called CoV 
infectious disease (COVID)-19, an infection originating 
in the upper airways. COVID-19 infection occurs mainly 
by air droplets and after a considerable introduction of 
viruses particles in closed and poorly ventilated rooms, 
at close contact with the presumed positive person; also 
by contact with contaminated objects, where COVID-19 
can survive for some hours [1], [2], [3].
Then, it is spread through direct or indirect 
contact with the oral, the nasal cavity and the eye 
mucous membranes. At this level, SARS-Cov2 seems 
to cause chemosensory dysfunction as ageusia and 
anosmia [2].
The most likely cause for transient hypogeusia 
and hyposmia in SARS-CoV2-infected patients is a direct 
contact and interaction of the virus with gustatory receptors 
or olfactory receptor cells [3]. The oral mucosa could be 
stimulated by speaking, coughing, and sneezing and viral 
particles have the ability to become aerosolized; they 
can stay in the air for 3 or more hours and may spread to 
contaminate multiple surfaces in the surrounding area [4]. 
As a consequence, the SARS-CoV-2 became able to 
interfere with both respiratory and oral environment, also 
determining temporary (and perhaps permanent) 
damages of central nervous system [5], [6].
Given the capability of the SARS-CoV-2 of 
surviving over surfaces for several hours, it is crucial to 
perform an appropriate disinfection of the oral mucosa 
before any intervention [7], [8]. Furthermore, arising 
evidences exist about the positive action of antiviral 
and anti-allergic drugs in the oral district that seems to 
be useful in ameliorating the inflammatory status and 
reducing potential infection transmission. However, at 
least 10 clinical trials have been started to evaluate the 
efficacy and potential side effects of other products, 
including the ones used for oral hygiene [7], [8], [9].
While studies on virucidal activity of povidone-
iodine (PVP-I) have not yet been performed specifically 
on SARS-CoV-2, several in vitro studies demonstrated 
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its effectiveness against multiple viruses including related 
CoVs; for example, Eggers et al. examined a diluted 
PVP-I (0.23%) formulation against SARS-CoV-1, MERS-
CoV, and influenza A (H1N1) applied for 15 s and found 
>99.99% reduction of viral titers [10]. Mouthwash/gargles 
for 1 min with a solution of PVP-I diluted 1:3 (for 7.5% PVP-
I) or 1:4 (for 10% PVP-I) to achieve <3% concentration 
is safe and may help to reduce the viral load and the 
potential aerosolization of SARS-CoV-2. It could be 
effective to reduce viral load from asymptomatic COVID-
19 patients, also providing a protective oropharyngeal 
hygiene measure for the health professionals. Moreover, 
as suggested by Sampson [11], oral hygiene should be 
improved during a COVID-19 infection aiming to reduce 
the bacterial load in the mouth and the risk of a bacterial 
superinfection. These easy-to-do, cost saving tips may be 
performed in any dental setting and effective to reduce the 
risk of severe infections [12], [13], [14]. Our suggestion 
is to maintain an extremely high level of oral hygiene to 
avoid any dental emergencies, therefore, patients should 
wash their teeth at least twice a day, floss daily, and use 
a PVP-I mouthwash thrice a day. This not only reduce 
the risk of dental emergencies but the oral viral load also 
and might, even if there is no evidence, reduce the risk of 
contaminating the surrounding environment [15], [16], [17].
By the way, based on the current literature, we 
can use local iodine-based products associated with 
systemic antiviral and anti-inflammatory drugs to avoid 
the infection spreading [18], [19], [20].
Conclusion
We must deepen our knowledge about 
SARS-CoV-2 biology and better understand the oral 
pathophysiology of COVID-19 to establish specific 
protocols to prevent its transmission and clinical 
consequences.
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